Severe deficiencies, especially those with neurological symptoms (numbness, tingling, memory issues), often require a more intensive initial treatment plan to rapidly restore healthy B12 levels and prevent lasting nerve damage
- The associated drug administration procedure must be reported separately using the appropriate CPT drug administration codes based on the payer or Medicare contractor guidelines
However, because AOD9604 is often selfadministered outside clinical settings, the safety margin can vary depending on sourcing, dosing accuracy, and overall protocol design
A response usually is seen within 48 to 72 hours, with brisk production of new red blood cells
Who should avoid GHK-CU Wilson's disease or copper metabolism disorders Active malignancies (until more research exists) Pregnancy and breastfeeding Known copper sensitivity or allergy Those unable to maintain sterile injection technique When uncertain, consult a healthcare provider familiar with peptide research